Filing Flows

Filing Flows › Energy › Core Laboratories (CLB)

Core Laboratories (CLB) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Oct 30, 2026 · Core Laboratories (CLB) Q3 2026 earnings results →

Q3 2026 Revenue down 2% year over year to $132M · 4¢ of every $1 of revenue kept as net profit · operating margin 9.1%

Core Laboratories made $132M in Q3 2026 (-2% Y/Y): Service $96.0M, Product $36.1M. Operating margin 9.1%, net earnings $5.4M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Oct 30, 2026.

Revenue$132M
Year over year-2%
Operating margin9.1%
Net earnings$5.4M
Operating cash flow$5.0M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $132.1M in Q3 2026, down 2% year over year and up 6% from the previous quarter. Service was the largest line at 73% of revenue. Service lost $5.1M year over year (down 5%), 209% of the total change.

Operating profit was $12.1M, a 9.1% margin (down 6.4 points year over year). Total costs grew 6% against a revenue fall of 2%. Net earnings were $5.4M, down 62% year over year. The effective tax rate was 41.1%.

Operating cash flow was $5.0M (down 42% year over year), 91% of net earnings. Non-cash charges added back $3.7M of depreciation and amortization and $1.3M of share-based compensation. Working capital and other items used $5.5M. After capital expenditures - operations ($3.2M), free cash flow as the company reports it was $1.7M.

Quarterly history

Core Laboratories revenue by quarterCore Laboratories revenue by quarter$124MQ1 2025$130MQ2 2025$135MQ3 2025$138MQ4 2025$122MQ1 2026$125MQ2 2026$132MQ3 2026
Core Laboratories net earnings by quarterCore Laboratories net earnings by quarter$69KQ1 2025$10.6MQ2 2025$14.2MQ3 2025$4.9MQ4 2025−$753KQ1 2026$6.0MQ2 2026$5.4MQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QOct 30, 2026$132M-2%9.1%$5.4M$5.0M
Q2 202610-QJul 30, 2026$125M-4%7.3%$6.0M$7.8M
Q1 202610-QMay 1, 2026$122M-1%1.5%−$753K$4.0M
Q4 202510-KMar 23, 2026$138M+7%11.5%$4.9M$7.9M
Q3 202510-QOct 23, 2025$135M+0.1%15.6%$14.2M$8.5M
Q2 202510-QJul 25, 2025$130M-0.3%11.7%$10.6M$13.9M
Q1 202510-QApr 28, 2025$124M-5%3.6%$69K$6.7M

Charts

Core Laboratories: revenue growth, year over year and quarter over quarterCore Laboratories: revenue growth, year over year and quarter over quarterY/YQ/Q-5%Q1 20250%+5%Q2 2025+0%+3%Q3 2025+7%+3%Q4 2025-1%-12%Q1 2026-4%+2%Q2 2026-2%+6%Q3 2026
Latest (Q3 2026): Y/Y -2%, Q/Q +6%.
Core Laboratories: where the cash came from (+) and went (−), TTM to Q3 2026Core Laboratories: where the cash came from (+) and went (−), TTM to Q3 2026Operating cash flow$24.7MCapital spending−$14.3MBuybacks−$10.4MCash drawn (+) / kept (−)$4.3MAsset & business sales$3.8MOther investing−$3.1MNet borrowing (+) / repaid (−)−$2.2MDividends−$1.8MAcquisitions−$620KOther financing−$186K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Core Laboratories: profit against cash, quarter by quarterCore Laboratories: profit against cash, quarter by quarterNet incomeOperating cash flow$7.5M$20.6MQ4 2024$69K$6.7MQ1 2025$10.7M$13.9MQ2 2025$14.5M$8.5MQ3 2025$5.1M$7.9MQ4 2025−$753K$4.0MQ1 2026$5.8M$7.8MQ2 2026$5.5M$5.0MQ3 2026
Latest (Q3 2026): Net income $5.5M, Operating cash flow $5.0M.
Core Laboratories: diluted shares by fiscal yearCore Laboratories: diluted shares by fiscal year47MFY202147MFY202248MFY202348MFY202447MFY2025
+0.7% since FY2021: more shares outstanding (issuance, stock pay).
Core Laboratories in its industry: growth against margin (19 companies, SIC 1389)Core Laboratories in its industry: growth against margin (19 companies, SIC 1389)revenue growth, year over year →↑ operating marginmedian +11%median 7%SLBHALLBRTOIINESRACDCRESXPROWTTRPUMPHOSWBIKLXERNGRNINENGSNCS Multistage Holdings, Inc.TUSKCLB (-2%, 9%)
Oil & Gas Field Services, NEC; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Core Laboratories

Core Laboratories Inc. is a Delaware corporation. We were established in 1936 and are one of the world’s leading providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, primarily through client relationships with many of the world’s major, national and independent oil companies. These services and products can enable our clients to evaluate and improve reservoir performance and increase oil and gas recovery from their new and existing fields. We make measurements on reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. In addition, we assist clients in evaluating subsurface targets associated with Carbon Capture and Sequestration (“CCS”) projects or initiatives. We have over 70 offices in more than 50 countries and have approximately 3,300 employees.

In its own words, from its 10-K, filed Mar 23, 2026.

Core Laboratories against its Oil & Gas Field Services, NEC peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -2% against the peers' median +6%. Operating margin: 9.1% against the peers' median 9.1%.

CompanyQuarterRevenueY/YOp. margin
CLB Core LaboratoriesQ3 2026$132M-2%9.1%
SLB SLB LimitedQ3 2026$9.4B+6%10.8%
HAL HalliburtonQ3 2026$5.7B+2%10.9%
LBRT Liberty EnergyQ3 2026$1.2B+26%1.6%
OII Oceaneering InternationalQ3 2026$785M+6%11.7%
NESR National Energy Services ReunitedQ2 2026$521M+59%12.5%
ACDC ProFrac HoldingQ3 2026$511M+27%-6.7%
RES RPCQ3 2026$468M+5%-11.5%
XPRO ExproQ3 2026$440M+7%1.1%

Source: Core Laboratories 10-Q on SEC EDGAR · CIK 1958086 · Oil & Gas Field Services, NEC

Guidance and outlook

Core Laboratories: what its forward-looking statements are about (10-Q filed 2026-10-30)Core Laboratories: what its forward-looking statements are about (10-Q filed 2026-10-30)Other6Demand5Financing2Margins2Capital spending1Tax1
17 statements; tone +0.00 (−1 all cautious, +1 all confident); 1 hedged.
Core Laboratories: outlook statements against the filing beforeCore Laboratories: outlook statements against the filing beforeConfident4Cautious4

13F: who owns CLB and who is buying

Largest holders of CLB (13F)Largest holders of CLB (13F)Ariel Investments, LLC$164MBlackRock$86.9MVanguard Group$49.4MDisciplined Growth Investors$35.4MEarnest Partners LLC$34.3MState Street$25.4MCWA Asset Management Group, LLC$20.4MVanguard Capital Management LLC$18.5MDimensional Fund Advisors LP$18.0MSchroder Investment Management$16.9M
Funds' net buying of CLB by quarter (13F)Funds' net buying of CLB by quarter (13F)$14.0M2024-09−$11.9M2024-12$1.9M2025-03$15.9M2025-06−$15.9M2025-09−$2.2M2025-12−$10.7M2026-03$25.1M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on CLB

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results

Compare CLB with

中文版:Core Laboratories(CLB)财报

Español · Français